Toast Acquires xtraCHEF to Empower Restaurants with Insights into Menu Profitability and Accounts Payable Automation

June 11, 2021

Acquisition follows successful partnership launched in June 2020 Toast, the end-to-end cloud platform purpose-built for the restaurant community, today announced it acquired XtraCHEF, a suite of back office tools for restaurants, including accounts payable automation and inventory management. Designed from the ground-up for restaurants of all sizes, xtraCHEF arms operators to take control of rising […]

Read More

KOP Clinical Payments Company Greenphire Set to be Acquired by Thoma Bravo

May 27, 2021

Private equity firm Thoma Bravo will acquire King of Prussia-based Greenphire via a strategic investment, the companies announced Wednesday. Thoma Bravo is purchasing the clinical trial payment company from The Riverside Company in a deal that is expected to close by the end of this fiscal quarter. Financial details of the deal were not disclosed. […]

Read More

RealLIST Connectors 2021: Meet 20 People Changing Philadelphia’s Innovation Ecosystem for Good

May 25, 2021

In a time of distance and division, local innovators are working to bring people together for good. Last year, set out to create a comprehensive look at who’s connecting the Philly tech community, especially amid a pandemic and widespread societal inequities. RealLIST Connectors was born. The concept was this: If you’re brand new on […]

Read More

B2B Software Company Piano Raises $88M Series C, with Strategic Investment From LinkedIn

May 18, 2021

Since software company Piano raised its Series B in early 2019, it has upped its local headcount and moved into The Bourse in Old City. Now, two years and a global pandemic later, leaders at the B2B company said they have raised an $88 million Series C round of venture funding, and are looking forward […]

Read More

PolyCore Therapeutics Awarded Supplemental NINDS Grant to Understand the Effects of its Lead Compound, PCT-3012, to Treat Cognitive Impairment in Alzheimer’s disease

May 17, 2021

PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders, today announced that it has been awarded a $456,000 Phase II SBIR supplemental grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) to fund research of […]

Read More